OAKLEY PRESCRIPTIONS LIMITED - LONDON
Company Profile | Company Filings |
Overview
OAKLEY PRESCRIPTIONS LIMITED is a Private Limited Company from LONDON ENGLAND and has the status: Active.
OAKLEY PRESCRIPTIONS LIMITED was incorporated 6 years ago on 02/02/2018 and has the registered number: 11183748. The accounts status is UNAUDITED ABRIDGED and accounts are next due on 31/12/2024.
OAKLEY PRESCRIPTIONS LIMITED was incorporated 6 years ago on 02/02/2018 and has the registered number: 11183748. The accounts status is UNAUDITED ABRIDGED and accounts are next due on 31/12/2024.
OAKLEY PRESCRIPTIONS LIMITED - LONDON
This company is listed in the following categories:
47730 - Dispensing chemist in specialised stores
47730 - Dispensing chemist in specialised stores
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 3 | 31/03/2023 | 31/12/2024 |
Registered Office
167 UXBRIDGE ROAD
LONDON
W7 3TH
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
04/12/2023 | 18/12/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR BENJAMIN KWADWO TUFFOUR | Dec 1976 | British | Director | 2018-02-02 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Tuffour Pharm Group Limited | 2018-05-18 | Colchester Essex |
Ownership of shares 75 to 100 percent as firm Voting rights 75 to 100 percent as firm |
|
Mr Benjamin Tuffour | 2018-02-02 - 2018-05-18 | 12/1976 | Colchester Essex | Ownership of shares 75 to 100 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Oakley Prescriptions Limited | 2023-12-22 | 31-03-2023 | |
OAKLEY_PRESCRIPTIONS_LIMI - Accounts | 2022-07-19 | 31-03-2022 | |
OAKLEY_PRESCRIPTIONS_LIMI - Accounts | 2021-09-10 | 31-03-2021 | £36,665 Cash |
OAKLEY_PRESCRIPTIONS_LIMI - Accounts | 2019-03-13 | 28-02-2019 | £40,909 equity |